Physician profile
Keith Watson
NPI 1194795948
$1,955.53
in general payments reported to CMS, 2019-2025
12 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.42 · 2021: $329 · 2022: $16.03 · 2023: $1,456 · 2024: $20.30 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $971 · Food and Beverage: $614.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $970.76 |
| Food and Beverage | $613.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,356.63 | 2023-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Kala Pharmaceuticals, INC. | $124.62 | 2021 | |
| Eyevance Pharmaceuticals LLC | $121.80 | 2021 | |
| Astellas Pharma US INC | $115.20 | 2023 | |
| Coopervision INC. | $79.65 | 2021-2025 | Myday Contact Lens, Misight Contact Lens |
| Biotissue Holdings INC. | $34.11 | 2025 | |
| Sun Pharmaceutical Industries INC. | $31.89 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $25.50 | 2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.68 | 2021 | |
| Oyster Point Pharma, INC. | $16.03 | 2022 | |
| Maculogix, INC. | $14.99 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.